Anticoagulants may prolong lives of prostate cancer patients

02/22/2013 | HealthDay News

Researchers tracked nearly 250 patients with advanced or spreading prostate cancer and found that those treated with anticoagulants such as heparin and warfarin lived longer than those who didn't receive the medications. Use of blood thinners was associated with a 39% increase in overall survival. The study looked at patients being treated with chemotherapy and was reported at a meeting of the American Society of Clinical Oncology.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD